156 related articles for article (PubMed ID: 34834478)
1. The 2-Year Leakage Index and Quantitative Microaneurysm Results of the RECOVERY Study: Quantitative Ultra-Widefield Findings in Proliferative Diabetic Retinopathy Treated with Intravitreal Aflibercept.
Babiuch AS; Wykoff CC; Yordi S; Yu H; Srivastava SK; Hu M; Le TK; Lunasco L; Reese J; Nittala MG; Sadda SR; Ehlers JP
J Pers Med; 2021 Nov; 11(11):. PubMed ID: 34834478
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal panretinal microaneurysm dynamics on ultra-widefield fluorescein angiography in eyes treated with intravitreal aflibercept for proliferative diabetic retinopathy in the recovery study.
Babiuch A; Wykoff CC; Hach J; Srivastava S; Talcott KE; Yu HJ; Nittala M; Sadda S; Ip MS; Le T; Hu M; Reese J; Ehlers JP
Br J Ophthalmol; 2021 Aug; 105(8):1111-1115. PubMed ID: 32829304
[TBL] [Abstract][Full Text] [Related]
3. RETINAL LEAKAGE INDEX DYNAMICS ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY IN EYES TREATED WITH INTRAVITREAL AFLIBERCEPT FOR PROLIFERATIVE DIABETIC RETINOPATHY IN THE RECOVERY STUDY.
Babiuch AS; Wykoff CC; Srivastava SK; Talcott K; Zhou B; Hach J; Hu M; Reese JL; Ehlers JP
Retina; 2020 Nov; 40(11):2175-2183. PubMed ID: 31917731
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Quantitative Ultrawidefield Angiographic Features in Diabetic Retinopathy Treated with Aflibercept from the Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement Trial.
Kalra G; Wykoff C; Martin A; Srivastava SK; Reese J; Ehlers JP
Ophthalmol Retina; 2024 Feb; 8(2):116-125. PubMed ID: 37696393
[TBL] [Abstract][Full Text] [Related]
5. Quantitative Ultra-Widefield Angiographic Features and Associations with Diabetic Macular Edema.
Jiang AC; Srivastava SK; Hu M; Figueiredo N; Babiuch A; Boss JD; Reese JL; Ehlers JP
Ophthalmol Retina; 2020 Jan; 4(1):49-56. PubMed ID: 31690541
[TBL] [Abstract][Full Text] [Related]
6. Real-Time Diabetic Retinopathy Severity Score Level versus Ultra-Widefield Leakage Index-Guided Management of Diabetic Retinopathy: Two-Year Outcomes from the Randomized PRIME Trial.
Yu HJ; Ehlers JP; Sevgi DD; O'Connell M; Reese JL; Srivastava SK; Wykoff CC
J Pers Med; 2021 Sep; 11(9):. PubMed ID: 34575662
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal Quantitative Ultrawide-field Fluorescein Angiography Dynamics in the RUBY Diabetic Macular Edema Study.
Sarici K; Yordi S; Martin A; Lunasco L; Mugnaini C; Chu K; Moini H; Vitti R; Srivastava SK; Ehlers JP
Ophthalmol Retina; 2023 Jun; 7(6):543-552. PubMed ID: 36736895
[TBL] [Abstract][Full Text] [Related]
8. Association of Subregional Quantitative Ultra-widefield Fluorescence Angiography Characteristics With the Occurrence of Diabetic Macular Edema and Proliferative Diabetic Retinopathy.
Sun G; Wang X; Jiang J; Yi Z; Fu M; Yang X; Zheng H; Chen C
Front Med (Lausanne); 2021; 8():720564. PubMed ID: 34631745
[No Abstract] [Full Text] [Related]
9. Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.
Wykoff CC; Nittala MG; Zhou B; Fan W; Velaga SB; Lampen SIR; Rusakevich AM; Ehlers JP; Babiuch A; Brown DM; Ip MS; Sadda SR;
Ophthalmol Retina; 2019 Dec; 3(12):1076-1086. PubMed ID: 31542339
[TBL] [Abstract][Full Text] [Related]
10. Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy.
Wykoff CC; Nittala MG; Villanueva Boone C; Yu HJ; Fan W; Velaga SB; Ehlers JP; Ip MS; Sadda SR;
Ophthalmol Retina; 2022 Jul; 6(7):557-566. PubMed ID: 35257962
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal Panretinal Leakage and Ischemic Indices in Retinal Vascular Disease after Aflibercept Therapy: The PERMEATE Study.
Figueiredo N; Srivastava SK; Singh RP; Babiuch A; Sharma S; Rachitskaya A; Talcott K; Reese J; Hu M; Ehlers JP
Ophthalmol Retina; 2020 Feb; 4(2):154-163. PubMed ID: 31757691
[TBL] [Abstract][Full Text] [Related]
12. Baseline Factors Affecting Changes in Diabetic Retinopathy Severity Scale Score After Intravitreal Aflibercept or Laser for Diabetic Macular Edema: Post Hoc Analyses from VISTA and VIVID.
Dhoot DS; Baker K; Saroj N; Vitti R; Berliner AJ; Metzig C; Thompson D; Singh RP
Ophthalmology; 2018 Jan; 125(1):51-56. PubMed ID: 28764888
[TBL] [Abstract][Full Text] [Related]
13. Quantitative Ultra-Widefield Angiography and Diabetic Retinopathy Severity: An Assessment of Panretinal Leakage Index, Ischemic Index and Microaneurysm Count.
Ehlers JP; Jiang AC; Boss JD; Hu M; Figueiredo N; Babiuch A; Talcott K; Sharma S; Hach J; Le T; Rogozinski A; Lunasco L; Reese JL; Srivastava SK
Ophthalmology; 2019 Nov; 126(11):1527-1532. PubMed ID: 31383482
[TBL] [Abstract][Full Text] [Related]
14. Proliferative Diabetic Retinopathy Events in Patients With Diabetic Macular Edema: Post Hoc Analysis of VISTA and VIVID Trials.
Do DV; Gordon C; Suñer IJ; Reed K; Moini H; Gibson A; Du W; Shah CP
J Vitreoretin Dis; 2022; 6(4):295-301. PubMed ID: 37007930
[TBL] [Abstract][Full Text] [Related]
15. Real-Time Photographic- and Fluorescein Angiographic-Guided Management of Diabetic Retinopathy: Randomized PRIME Trial Outcomes.
Yu HJ; Ehlers JP; Sevgi DD; Hach J; O'Connell M; Reese JL; Srivastava SK; Wykoff CC
Am J Ophthalmol; 2021 Jun; 226():126-136. PubMed ID: 33529593
[TBL] [Abstract][Full Text] [Related]
16. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
Alagorie AR; Nittala MG; Velaga S; Zhou B; Rusakevich AM; Wykoff CC; Sadda SR
JAMA Ophthalmol; 2020 Aug; 138(8):851-857. PubMed ID: 32584384
[TBL] [Abstract][Full Text] [Related]
17. Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
Brown DM; Schmidt-Erfurth U; Do DV; Holz FG; Boyer DS; Midena E; Heier JS; Terasaki H; Kaiser PK; Marcus DM; Nguyen QD; Jaffe GJ; Slakter JS; Simader C; Soo Y; Schmelter T; Yancopoulos GD; Stahl N; Vitti R; Berliner AJ; Zeitz O; Metzig C; Korobelnik JF
Ophthalmology; 2015 Oct; 122(10):2044-52. PubMed ID: 26198808
[TBL] [Abstract][Full Text] [Related]
18. Intravitreal Aflibercept for Diabetic Macular Edema: 148-Week Results from the VISTA and VIVID Studies.
Heier JS; Korobelnik JF; Brown DM; Schmidt-Erfurth U; Do DV; Midena E; Boyer DS; Terasaki H; Kaiser PK; Marcus DM; Nguyen QD; Jaffe GJ; Slakter JS; Simader C; Soo Y; Schmelter T; Vitti R; Berliner AJ; Zeitz O; Metzig C; Holz FG
Ophthalmology; 2016 Nov; 123(11):2376-2385. PubMed ID: 27651226
[TBL] [Abstract][Full Text] [Related]
19. One-year follow-up of ischemic index changes after intravitreal dexamethasone implant for diabetic macular edema: an ultra-widefield fluorescein angiography study.
Borrelli E; Parravano M; Querques L; Sacconi R; Giorno P; De Geronimo D; Bandello F; Querques G
Acta Diabetol; 2020 May; 57(5):543-548. PubMed ID: 31749052
[TBL] [Abstract][Full Text] [Related]
20. The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography.
Antaki F; Coussa RG; Mikhail M; Archambault C; Lederer DE
Graefes Arch Clin Exp Ophthalmol; 2020 Dec; 258(12):2681-2690. PubMed ID: 32676792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
